These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35603214)

  • 1. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease.
    Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M
    Front Immunol; 2022; 13():866701. PubMed ID: 35603214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
    Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
    Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Pak K; Huang W; Selva-O'Callaghan A; Albayda J; Casciola-Rosen L; Paik JJ; Tiniakou E; Mecoli CA; Lloyd TE; Danoff SK; Christopher-Stine L; Mammen AL
    Arthritis Rheumatol; 2022 Mar; 74(3):508-517. PubMed ID: 34480833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
    Ge Y; Lu X; Peng Q; Shu X; Wang G
    PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-associated immune-mediated necrotizing myositis in Native Americans.
    Muruganandam M; Iqbal A; Akpan EB; Dolomisiewicz AC; Waters YM; Emil NS; Nunez SE; McElwee MK; O'Sullivan FX; Fields RA; Sibbitt WL
    Rheumatology (Oxford); 2022 Nov; 61(12):4855-4862. PubMed ID: 35348616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and clinical characteristics of anti-HMGCR (anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) antibodies in idiopathic inflammatory myopathy: an analysis from the MyoCite registry.
    Gupta L; Nune A; Naveen R; Verma R; Prasad P; Kharbanda R; Rathore U; Rai MK; Singh MK; Anuja AK; Agarwal V
    Rheumatol Int; 2022 Jul; 42(7):1143-1154. PubMed ID: 35031847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
    Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
    Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.
    Llansó L; Segarra-Casas A; Domínguez-González C; Malfatti E; Kapetanovic S; Rodríguez-Santiago B; de la Calle O; Blanco R; Dobrescu A; Nascimento-Osorio A; Paipa A; Hernandez-Lain A; Jou C; Mariscal A; González-Mera L; Arteche A; Lleixà C; Caballero-Ávila M; Carbayo Á; Vesperinas A; Querol L; Gallardo E; Olivé M
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
    Kishi T; Rider LG; Pak K; Barillas-Arias L; Henrickson M; McCarthy PL; Shaham B; Weiss PF; Horkayne-Szakaly I; Targoff IN; Miller FW; Mammen AL;
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1088-1094. PubMed ID: 28129483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
    Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
    Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.